Versant Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 25

Professionals
  • Investments
  • 473

  • Portfolio
  • 53

  • Exits
  • 212

Exits

Versant Ventures General Information

Description

Founded in 1999, Versant Ventures is a venture capital firm based in San Francisco, California. The firm seeks to invest in the manufacturing, life sciences, oncology, industrials, impact investing, and pharmaceuticals sectors.

Contact Information

Year Founded
1999
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • One Sansome Street
  • Suite 3630
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

Versant Ventures Investments (473)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Belharra Therapeutics 04-Jan-2023 Early Stage VC 0000 Drug Delivery Generating Revenue 000000 0000000 00.0
000000000 00000000 09-Dec-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000000 000000 00.0
0000 000000000000 22-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue 00000 00000 00.0
000000 21-Nov-2022 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000 0000000 00.0
00000 000000000000 15-Nov-2022 00000 00000 00000 Drug Discovery Pre-Clinical Trials 00000 0000000 00.0
0000 000000000000 15-Nov-2022 00000 00000 0000 Biotechnology Stealth 00000 0000000 00.0
000000 00000000000 06-Oct-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 0000000 00.0
00000 000000000000 12-Sep-2022 00000 00000 000.00 Biotechnology Startup
Vector Biopharma 10-Aug-2022 Early Stage VC 0000 Discovery Tools (Healthcare) Startup 000000000 000000 00.0
Tempest Therapeutics 29-Apr-2022 PIPE 0000 Drug Discovery Generating Revenue 000000 0000000 00.0
You’re viewing 10 of 473 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Versant Ventures Exits (212)

Company Name Exit Date Exit Type Exit Size
Akero Therapeutics 17-Jun-2022 Secondary Transaction - Open Market 0000
0000000 0000000000 24-Mar-2022 000 00 00000000
0000000 07-Jan-2022 000000000000000000 00000
0000000 (000000000 26-Oct-2021 000 0000
000 0000000 01-Oct-2021 000000000 00000000
00000 29-Sep-2021 0000000000: 000000
00000000 000000000 01-Aug-2021 000000000000000000 00.00
0000000 000000 01-Jul-2021 000000000 00000000
Tempest Therapeutics 28-Jun-2021 Reverse Merger
Graphite Bio 25-Jun-2021 IPO 00000
You’re viewing 10 of 212 exits. Get the full list »

Versant Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Versant Ventures‘s full profile, request access.

Request a free trial

Versant Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Versant Ventures Team (68)

Name Title Deals Funds Boards Office
Charles Warden Co-Founder and Managing Director 00 0 0 San Francisco, CA
Barbara Lubash Co-Founder & Managing Director 00 0 0 San Francisco, CA
Donald Milder Co-Founder & Managing Director 0 0 0 San Francisco, CA
Rebecca Robertson Co-Founder & Managing Director 00 0 0 San Francisco, CA
Ross Jaffe MD Co-Founder & Managing Director 00 0 0 San Francisco, CA
You’re viewing 5 of 68 team members. Get the full list »

Versant Ventures Co-Investors (177)

Name With Exits Lead Partner Series Industry
OrbiMed 11 0 0 Series chart Industry bar
RA Capital Management 00 0 00 Series chart Industry bar
Logos Capital 0 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
Casdin Capital 0 0 0 Series chart Industry bar
You’re viewing 5 of 177 co-investors. Get the full list »